Justin Gumas

Justin is a PhD student in the Biology and Molecular Pharmacology program. He graduated with a BS in biochemistry from Temple University in 2017, then from 2017 to 2019 he worked as a research technician at the University of Pennsylvania in a lab studying small peptide inhibitors of the complement system.

2024

• Shigematsu, M, Matsubara, R, Gumas, J, Kawamura, T, Kirino, Y. Angiogenin-catalyzed cleavage within tRNA anticodon-loops identified by cP-RNA-seq. Biosci Biotechnol Biochem. 2024; :. doi: 10.1093/bbb/zbae192. PubMed PMID:39658364.
• Shigematsu, M., Gumas, J., Kirino, Y. cP-RNA-seq for tRNA half sequencing. Methods Enzymol. 2024; :. doi: 10.1016/bs.mie.2024.11.002.
• Gumas, J, Kawamura, T, Shigematsu, M, Kirino, Y. Immunostimulatory short non-coding RNAs in the circulation of patients with tuberculosis infection. Mol Ther Nucleic Acids. 2024;35 (1):102156. doi: 10.1016/j.omtn.2024.102156. PubMed PMID:38481936 PubMed Central PMC10933579.

2023

• Gumas, J., Kirino, Y. Extracellular tRNA-derived RNAs as emerging activators of endosomal Toll-like receptors: a narrative review. ExRNA. 2023; :. doi: 10.21037/exrna-22-22.

2022

• Gumas, J., Kirino, Y. Challenges inherent to the sequencing and quantification of short non-coding RNAs and how to address them. Clin Transl Disc. 2022; :. doi: 10.1002/ctd2.93.

2020

• Hughes, S, Gumas, J, Lee, R, Rumano, M, Berger, N, Gautam, AK, Sfyroera, G, Chan, AL, Gnanaguru, G, Connor, KM, Kim, BJ, Dunaief, JL, Ricklin, D, Hajishengallis, G, Yancopoulou, D, Reis, ES, Mastellos, DC, Lambris, JD. Prolonged intraocular residence and retinal tissue distribution of a fourth-generation compstatin-based C3 inhibitor in non-human primates. Clin Immunol. 2020 May;214:108391. doi: 10.1016/j.clim.2020.108391. PubMed PMID:32229292.

2018

• Reis, ES, Berger, N, Wang, X, Koutsogiannaki, S, Doot, RK, Gumas, JT, Foukas, PG, Resuello, RRG, Tuplano, JV, Kukis, D, Tarantal, AF, Young, AJ, Kajikawa, T, Soulika, AM, Mastellos, DC, Yancopoulou, D, Biglarnia, AR, Huber-Lang, M, Hajishengallis, G, Nilsson, B, Lambris, JD. Safety profile after prolonged C3 inhibition. Clin Immunol. 2018 Dec;197:96-106. doi: 10.1016/j.clim.2018.09.004. PubMed PMID:30217791.

Email: Justin.Gumas@jefferson.edu